Monte Rosa Therapeutics, Inc. GLUE Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s operating lease ROU assets?
- Monte Rosa Therapeutics, Inc. (GLUE) reported operating lease ROU assets of $24.69M in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s operating lease ROU assets decreased by 6.0% year-over-year, from $26.26M to $24.69M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.